Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
Provided By GlobeNewswire
Last update: May 14, 2024
PYX-201 Phase 1 trial clinical readout on track for fall of 2024
Executive Leadership Team expanded with the appointment of Stephen Worsley as Senior Vice President, Chief Business Officer
Read more at globenewswire.com
